BIG
PRME icon

Brooklyn Investment Group’s Prime Medicine PRME Stock Holding History

Brooklyn Investment Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39,967
Closed -$79.5K – 3395
2025
Q1 		$79.5K Buy
39,967
+38,073
+2,010% +$97.1K 0.02% 587
2024
Q4 		$5.53K Buy
+1,894
New +$6.65K ﹤0.01% 1174

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Brooklyn Investment Group's PRME Position: Q2 2025 in Review

Brooklyn Investment Group sold out of Prime Medicine (PRME) in Q2 2025, closing a stake of 39,967 shares — an estimated $79.5K sold.

Brooklyn Investment Group first reported a position in PRME in Q4 2024 and held it in 2 quarters. The position peaked at $79.5K in Q1 2025. 121 funds tracked by Wall St. Rank hold PRME as of Q2 2025.

  • Brooklyn Investment Group reported no remaining Prime Medicine position as of Q2 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 39,967 Prime Medicine shares in Q2 2025, an estimated $79.5K.
  • Brooklyn Investment Group first reported a position in Prime Medicine in Q4 2024 and held it in 2 quarters.
  • Brooklyn Investment Group's Prime Medicine position peaked at $79.5K in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2025.

Based on Brooklyn Investment Group's 13F filing for Q2 2025, filed 12 Aug 2025.